Upcoming Call:
Preview to Women’s Health Fund IV and FemTech III Portfolio Recap
August 13, 2025 | 9:30 AM PT
The FemTech III Fund is now fully deployed! Join our last monthly call on August 13th to celebrate this extraordinary milestone. During the first 30 minutes of the session, we'll share a preview of the Women's Health IV fund and an opportunity to meet the newest partner. The remainder of the session will be focused on a deep dive on the FemTech III fund portfolio and the partners will announce the fund's last 3 investments. If you can’t attend, you can listen to the recording on your dashboard when it’s more convenient.
Missed the last pitch call? Catch up here!
Annual Fund Performance Report
Portfolia’s 2024 Performance Reports are now available for all funds. COO Tammi Jantzen presented an overview on Understanding Performance Reports and K-1s. Missed the call? Watch the recording here.
As we focus on performance, the Rising America Funds continue to be among our highest performers with Fund I in the top 5% of all venture capital funds of its vintage year. With a strong focus in healthcare and fintech, secure your spot now in Rising America Fund III.
FemTech Fund III is a new 2023 vintage year fund and still deploying capital. According to Cambridge Associates, funds formed since 2023 are too young to have produced meaningful returns. FemTech Fund III invested in 9 portfolio companies as of 12/31/24 and expects to invest in a total of 14-16 companies.
EIN: 92-0418844
2024 FemTech III Fund Performance Updates
The 2024 financial statements are as of and for December 31, 2024. Please note all updates provided are confidential and not for distribution. To access the file, use password:
2024FT3Report!
Quarterly Reports
The highlights of Q1 2025 updates as provided by the company. Please note all updates provided are confidential and not for distribution.
To access the file, use password: Q125FT3!
FemTech III Portfolio Highlights
The Companies & Leadership Team
The Portfolia FemTech III Fund is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.
The Companies
A digital health platform that aims to solve healthcare fragmentation by unifying patient data and streamlining access to care
Developer of definitive tissue-based tests designed to diagnose and stage endometriosis.
FEMDX is a developer of cancer diagnosis devices designed to detect ovarian cancer.
Neuspera develops ultra-miniaturized, implantable medical devices for treating chronic conditions such as Overactive Bladder (OAB).
Simple Health Kit provides high-quality, accessible, and affordable diagnostic services for chronic health conditions.
Maude is setting new standards for sexual wellness and works closely with factories to create body-safe, accessible essentials for all.
A molecular diagnostics company at the intersection of epigenetics and AI tackling clinical problems such as infertility.
Attn Grace is a sustainable wellness brand designed for women, creating more sustainable solutions for women to combat bladder leakage.
Apollo Neuro offers a wearable consumer wellness device intended to help manage stress, challenging life transitions, and to promote a healthy lifestyle.
Portfolia Lead Partners
Companies In Diligence
If there are no companies in diligence currently, you can still volunteer and we'll contact you when a new one is being assembled
Refer A Company
The FemTech III fund will invest in 8-12 companies, from Seed to pre-IPO. We consider companies with solutions in the market, and we invest in both female- and male-led teams with a preference for gender-balanced executive teams. We only invest in companies with a U.S.-based C-Corp. Please submit the company information below or email companies@portfolia.com with questions.
Interested in other funds?
Connect with Investor Relations at investorrelations@portfolia.com
Additional questions?
Reach out to our team at members@portfolia.com